3rd Quarter - Report — ALKERMES, INC. for ALKERMES, INC. (2016)

Firm

ALKERMES, INC.

Client

ALKERMES, INC.

Income

—

Expenses

$1,150,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Maintain Medicare's six protected class status for depression and schizophrenia S. 648, Medicare Formulary Improvement Act of 2015

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
PETER NORMAN	—

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Health & Human Services, Dept of (HHS)

Bills named: S. 648 (114th)

Pharmacy PHA

Ensure regulatory certainty for clinical trials and subsequent scheduling of FDA-approved medicines deemed to be controlled substances. HR 6 the 21st Century Cures Act

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
PETER NORMAN	—

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); SENATE; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Health Issues HCR

Confronting the opioid and mental illness epidemic HR 2872, Opioid Addiction and Modernization Act HR 4981, Opioid Use Disorder Treatment Expansion and Modernization Act

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
PETER NORMAN	—

Contacted: Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ)

Bills named: H.R. 4981 (114th), H.R. 2872 (114th)

Alcohol and Drug Abuse ALC

Advance the use of FDA-approved medicines to treat addiction in criminal justice and public health settings S. 524/HR 953 Comprehensive Addiction and Recovery Act S. 1696/HR 3420 Departments of Labor, Health and Human Services, and Education and Related Agencies Act, 2016 (implementation of opioid treatment funding) Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2017. Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2017. Making appropriations for Labor, Health and Human Services, and Education and Related Agencies Act for the fiscal year ending September 30, 2017. Making appropriations for Commerce, Justice and Science for the fiscal year ending September 30, 2017.

Lobbyist	Covered position, as disclosed
ROBERT FORMAN	—
PETER NORMAN	—
DAVID TREWOLLA	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Bills named: H.R. 3420 (114th), S. 1696 (114th), S. 524 (114th), H.R. 953 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.